Common Contracts
1 similar Development and Licensing Agreement contracts
Second amendment to development and licensing agreement for oral parathyroid hormoneDevelopment and Licensing Agreement • November 2nd, 2020
This Amendment No. 2 (“Amendment No. 2”) dated as of October 14, 2003 (“Amendment Date”), to the License Agreement (referred to hereinafter as the “Agreement”) entered into as of the 13th of April, 2002, by and between Unigene Laboratories, Inc. (“Unigene”), a Delaware corporation, and SmithKline Beecham Corporation, a GlaxoSmithKline company (“GSK”), a Pennsylvania corporation.
